During the past decade, Universitatsklinikum Essen; Klinik für Dermatologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitatsklinikum Essen; Klinik für Dermatologie" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "University Hospital, Essen" with 3 trials sponsored, "3M" with 1 trials sponsored, "Dermatologic Cooperative Oncology Group" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitatsklinikum Essen; Klinik für Dermatologie" #1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator and "Ticeba GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitatsklinikum Essen; Klinik für Dermatologie" are "Aging" (2 trials), "Coronary Disease" (2 trials), "HIV Encephalopathy" (2 trials), "HIV Infections" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Universitatsklinikum Essen; Klinik für Dermatologie" in a lesser frequency.

Most popular intervention types in "Universitatsklinikum Essen; Klinik für Dermatologie" are "Drug" (5 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Cobimetinib" (2 trials), "Atezolizumab Placebo" (1 trials), "Coban 2" (1 trials) and "Interferon-alpha-2b" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinikum Essen; Klinik für Dermatologie" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Universitatsklinikum Essen; Klinik für Dermatologie". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Universitatsklinikum Essen; Klinik für Dermatologie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinikum Essen; Klinik für Dermatologie, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".